Effect of a Class III antiarrhythmic drug on the configuration of dose response curve for defibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 3, 1999, Pages 479-486

  Murakawa, Yuji ^a   Yamashita, Takeshi ^a   Kanese, Yukihiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antiarrhythmic drug; Defibrillation; Defibrillation threshold

Indexed keywords

ANTIARRHYTHMIC AGENT; NIFEKALANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEFIBRILLATION; DOG; DOSE RESPONSE; HEART FIBRILLATION; NONHUMAN; SHOCK WAVE; TREATMENT OUTCOME;

EID: 0033003870     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00476.x     Document Type: Article

References (32)

1. 1. Echt DS, Black JN, Barbey JT, et al. Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. Circulation 1989; 79: 1106-1117.
2. 2. Dorian P, Wang M, David I, et al. Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. Circulation 1991; 83:614-621.
3. 3. Dorian P, Newman D, Harris L, et al. Sotalol in patients with implanted automatic defibrillators: Effects on defibrillation and comparison with amiodarone. Can J Cardiol 1994; 10:193-200.
4. 4. Murakawa Y, Yamashita T, Ajiki K, et al. Effects of Class III antiarrhythmic drug and biphasic shocks on the postdefibrillation refractory period of relatively refractory myocardium. J Cardiovasc Electrophysiol 1996; 7:603-611.
5. 5. Murakawa Y, Yamashita T, Kanese Y, et al. Can a Class III antiarrhythmic drug improve electrical defibrillation efficacy during ventricular fibrillation? J Am Coll Cardiol 1997; 21:102-108
6. 6. Wesley RC Jr, Farkhani F, Morgan D, et al. Ibutilide: Enhanced defibrillation efficacy via plateau sodium current activation. Am J Physiol 1993; 264:H1269-H1274.
7. 7. Naccarelli GV, Dougherty AH, Wolbrette D. Antiarrhythmic drug-implantable cardioverter defibrillator interactions. In DP Zipes, J Jalife (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, PA, WB Saunders Company, 1995, pp. 1426-1433.
8. 8. Gwilt M, Blackburn KJ, Burges RA, et al. Electropharmacology of dofetilide, a new Class III agent, in anesthetized dogs. Eur J Pharmacol 1992; 215:137-144.
9. 9. Dorian P, Penkoske PA, Witkowski FX. Order in disorder: Effect of barium on ventricular fibrillation. Can J Cardiol 1996; 12:399-406.
10. 10. Jackman WM, Zipes DP. Low-energy synchronous cardioversion of ventricular tachycardia using a catheter electrode in a canine model of sub-acute myocardial infarction. Circulation 1982; 66: 187-195.
11. 11. Li HG, Yee R, Mehra R, et al. Effect of shock timing on efficacy and safety of internal cardioversion for ventricular tachycardia. J Am Coll Cardiol 1994; 24:703-708.
12. 12. Davy JM, Fain ES, Dorian P, et al. The relationship between successful defibrillation and delivered energy in open chest dogs: Reappraisal of the "defibrillation threshold" concept. Am Heart J 1987; 113:77-84.
13. 13. Hsia PW, Mahmud R. Genesis of sigmoidal dose-response curve during defibrillation by random shock: A theoretical model based on experimental evidence for a vulnerable window during ventricular fibrillation. PACE 1990; 13:1326-1342.
14. 14. Babbs CF. Effect of pentobarbital anesthesia on ventricular defibrillation threshold in dogs. Am Heart J 1978; 95:331-337.
15. 15. Murakawa Y, Gliner BE, Shanker B, et al. The effect of an unsuccessful subthreshold shock on the energy requirement for the subsequent defibrillation. Am Heart J 1989; 117:1065-1069.
16. 16. Jones DL, Irish WD, Klein GJ. Defibrillation efficacy: Comparison of defibrillation threshold versus dose-response curve determination. Circ Res 1991; 69:45-51.
17. 17. Gliner BE, Murakawa Y, Thakor NV. The defibrillation success rate versus energy relationship: Curve fitting and the most efficient defibrillation energy. PACE 1990; 13(Pt. I):326-338.
18. 18. Nakaya H, Tohse N, Takeda Y, et al. Effect of MS-551, a new Class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 1993; 109: 157-163.
19. 19. Sato R, Koumi S, Hisatome I, et al. A new Class III antiarrhythmic drug, MS-551, blocks the inward rectifier potassium channel in isolated guinea pig ventricular myocytes. J Pharmacol Exp Ther. 1995; 274:469-474.
20. 20. Tsuchihashi K, Curtis MJ. Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: Chemical defibrillation by Ito blockade? J Cardiovasc Pharmacol 1991; 18: 445-456.
21. 21. Ellingboe JW, Spinelli W, Winkley MW, et al. Class III antiarrhythmic activity of novel substitute 4-[(methylsulfonyl) amino] benzamides and sulfonamides. J Med Chem 1992; 21:705-716.
22. 22. Carlisle EJ, Allen JD, Bailey A, et al. Fourier analysis of ventricular fibrillation and synchronization of DC shocks in defibrillation. J Electrocardiol 1988; 21:337-343.
23. 23. Dorian P, Fain E, Davy JM, et al. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy. J Am Coll Cardiol 1986; 8:327-332.
24. 24. Peters W, Gang ES, Okazaki H, et al. Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog. Am Heart J. 1991; 122:1355-1360.
25. 25. Frame LH, Sheldon JH. Effect of recainam on the energy required for ventricular defibrillation in dogs as assessed with implanted electrodes. J Am Coll Cardiol 1988; 12:746-752.
26. 26. Fain ES, Dorian R, Davy JK, et al. Effects of encainide and its metabolites on energy requirements for defibrillation. Circulation 1986; 73: 1334-1341.
27. 27. Kerber RE, Pandian NG, Hoyt R, et al. Effect of ischemia, hypertrophy, hypoxia, acidosis and alkalosis on canine defibrillation. Am J Physiol 1983; 244:H825-H831.
28. + concentration. J Electrocardiol 1980; 13:73-78.
29. 29. Feeser SA, Tang ASL, Kavanagh KM, et al. Strength-duration and probability of success curves for defibrillation with biphasic waveform. Circulation 1990; 82:2128-2141.
30. 30. Ujhelyi MR, Schur M, Frede T, et al. Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic waveforms. Circulation 1995; 92:1644-1650.
31. 31. Deale OC, Wesley RC, Morgan D, et al. Nature of defibrillation: Determinism and probabilism. Am J Physiol 1990; 259:H1544-H1550.
32. 32. Singh BN. Controlling cardiac arrhythmias by lengthening repolarization: Historical overview. Am J Cardiol 1993; 26:18F-24F.